Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. AGM Information 2011

Aug 4, 2011

7082_rns_2011-08-04_3ea44915-f71c-4975-a70e-d6711b364e90.htm

AGM Information

Open in viewer

Opens in your device viewer

_________ false

C007��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7947Corporation no: 520013954Stock Exchange/Market: ���310428P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: [email protected] of transmission: 04/08/2011              Time of broadcast: 09:48 09:45:56

Reference: 2011-02-230961

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 19/09/2011 at 17:00 the corporation will hold it's annual general meetingat Teva's executive offices at 5 Basel street, Petach Tikva, IsraelNumber of the security that entitles its holder to vote at the meeting: 629014The Number - as given by the Tel Aviv Stock Exchange

According to section 182 C of the Companies law, 5759-1999, only shareholders of record at the close of business 10/08/2011 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report proxyheb_isa.pdf

Attached hereto is the proxy statement proxyenglish_isa.pdf

Attached is the full Proxies in English and in Hebrew
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 29/06/2011
- - -
Name of the Signatory: : Egosi Richard , Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary , Name of Employer Company: .
Basel Telephone: 03-9267513 , Facsimile: 03-9267429 , E-mail: [email protected] 2